Actionable news
0
All posts from Actionable news
Actionable news in CXRX: CONCORDIA HEALTHCARE CORP,

Concordia International Announces Release Date for Second Quarter 2016 Results

TORONTO, July 19, 2016 /PRNewswire/ - Concordia International Corp. ("Concordia" or "the Company") (CXRX) (CXR.TO) today announced it intends to release its second quarter 2016 financial results before market open on Friday, August 12, 2016.

The Company will subsequently hold a conference call that same day, Friday, August 12, 2016, at 8:30 a.m. ET hosted by Mr. Mark Thompson, Chairman and Chief Executive Officer and other senior management. A question-and-answer session will follow the corporate update.

CONFERENCE CALL DETAILS

DATE:

Friday, August 12, 2016

TIME:

8:30 a.m. ET

DIAL-IN NUMBER:

(647) 427-7450 or (888) 231-8191

TAPED REPLAY:

(416) 849-0833 or (855) 859-2056

REFERENCE NUMBER:

47384572

This call is being webcast and can be accessed by going to:
http://event.on24.com/r.htm?e=1222491&s=1&k=9E399029EFF2EB0AA57B0351DEA8DB6A

An archived replay of the webcast will be available by clicking the link above.

Concordia is a diverse, international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs. The Company has an international footprint with sales in more than 100 countries, and has a diversified portfolio of more than 200 established, off-patent molecules that make up more than 1,300 SKUs. Concordia also markets orphan drugs through its Orphan Drug Division, consisting of Photofrin® for the treatment of certain rare forms of cancer, which is...


More